torrent pharmaceuticals
Jump to
457 Results Found
  • Torrent Pharma Consolidated December 2018 Net Sales at Rs 2,051.00 crore, up 38.86% Y-o-Y Jan 30, 2019 05:02 PM IST

    Torrent Pharma Consolidated December 2018 Net Sales at Rs 2,051.00 crore, up 38.86% Y-o-Y

  • Torrent Pharma Standalone December 2018 Net Sales at Rs 1,481.00 crore, up 42.27% Y-o-Y Jan 30, 2019 04:57 PM IST

    Torrent Pharma Standalone December 2018 Net Sales at Rs 1,481.00 crore, up 42.27% Y-o-Y

  • Torrent recalls 16 lots of hypertensive drug from US due to impure API Jan 23, 2019 03:27 PM IST

    Torrent recalls 16 lots of hypertensive drug from US due to impure API

    According to an announcement made by Torrent to the US Food and Drug Administration on January 22, the impurity detected in the API is N-nitrosodiethylamine (NDEA).

  • Buy Torrent Pharmaceuticals, target Rs 2050: Ashish Chaturmohta Jan 17, 2019 11:39 AM IST

    Buy Torrent Pharmaceuticals, target Rs 2050: Ashish Chaturmohta

    It can be bought at current levels and on dips to Rs 1,860 with a stop loss below Rs 1,780 for the target of Rs 2,050, says Ashish Chaturmohta of Sanctum Wealth Management.

  • 'Dabur, Axis Bank among 5 stocks that could return up to 15% in a month' Jan 17, 2019 10:00 AM IST

    'Dabur, Axis Bank among 5 stocks that could return up to 15% in a month'

    On the upside, the index has resistance zone in the region of 10840-10870 levels. But, crossing above 11000 levels on a sustainable basis will confirm the uptrend.

  • Torrent Pharma gains 4% on redemption of non-convertible debentures Nov 30, 2018 11:40 AM IST

    Torrent Pharma gains 4% on redemption of non-convertible debentures

    The issued unsecured redeemable non-convertible debentures were worth Rs 500 crore.

  • Buy Torrent Pharmaceuticals; target of Rs 1850: ICICI Direct Nov 13, 2018 05:07 PM IST

    Buy Torrent Pharmaceuticals; target of Rs 1850: ICICI Direct

    ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated November 05, 2018.

  • Torrent Pharma Q2 profit dips 12%, but revenue jumps 34% on strong US, India biz Nov 03, 2018 05:42 PM IST

    Torrent Pharma Q2 profit dips 12%, but revenue jumps 34% on strong US, India biz

    Torrent Pharma said 7 ANDAs were filed during the quarter. As on September 2018, 35 ANDAs are pending approval and 5 tentative approvals have been received, it added.

  • Torrent Pharma recalls 14 lots of blood pressure drug from US Aug 21, 2018 07:42 PM IST

    Torrent Pharma recalls 14 lots of blood pressure drug from US

    The voluntarily recall of Valsartan/Amlodipine/HCTZ tablets to the consumer level is due to the detection of trace amounts of an unexpected impurity found.

  • Torrent Pharma consolidated Jun-2018 sales at Rs 1,872.00 crore Aug 03, 2018 11:39 AM IST

    Torrent Pharma consolidated Jun-2018 sales at Rs 1,872.00 crore

    Torrent Pharmaceuticals has reported a consolidated total income from operations of Rs 1,872.00 crore and a net profit of Rs 163.00 crore for the quarter ended Jun-2018

  • Torrent Pharma Q1 profit drops 13% to Rs 162 cr on higher amortisation, finance costs Aug 02, 2018 07:02 PM IST

    Torrent Pharma Q1 profit drops 13% to Rs 162 cr on higher amortisation, finance costs

    Torrent Pharma bought domestic formulation business of Unichem Laboratories Rs 3600 crore in December 2017.

  • Torrent Pharmaceuticals Q1 PAT may dip 8.4% YoY to Rs. 172.2 cr: Kotak Jul 18, 2018 03:54 PM IST

    Torrent Pharmaceuticals Q1 PAT may dip 8.4% YoY to Rs. 172.2 cr: Kotak

    Net Sales are expected to increase by 30.2 percent Y-o-Y (up 3.9 percent Q-o-Q) to Rs. 1,789.1 crore, according to Kotak.

  • Hold Torrent Pharmaceuticals; target of Rs 1333: Edelweiss Jul 13, 2018 05:02 PM IST

    Hold Torrent Pharmaceuticals; target of Rs 1333: Edelweiss

    Edelweiss recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1333 in its research report dated July 11, 2018.

  • Lavender Investments buys Torrent Pharma stake worth Rs 133 cr Jun 15, 2018 09:43 PM IST

    Lavender Investments buys Torrent Pharma stake worth Rs 133 cr

    According to the bulk deal data available with the BSE, the foreign investor disposed of 9.01 lakh shares, amounting to 0.53 percent stake in the drug firm.

  • Hold Torrent Pharmaceuticals; target of Rs 1333: Edelweiss Jun 12, 2018 02:43 PM IST

    Hold Torrent Pharmaceuticals; target of Rs 1333: Edelweiss

    Edelweiss recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1333 in its research report dated May 31, 2018.

  • Buy Torrent Pharmaceuticals; target of Rs 1485: Khambatta Securities Jun 11, 2018 05:13 PM IST

    Buy Torrent Pharmaceuticals; target of Rs 1485: Khambatta Securities

    Khambatta Securities is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1485 in its research report dated May 31, 2018.

  • Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss Apr 16, 2018 06:54 PM IST

    Torrent Pharmaceuticals Q4 PAT may dip 37.3% YoY to Rs. 129.3 cr: Edelweiss

    Net Sales are expected to increase by 11.5 percent Y-o-Y (up 8.3 percent Q-o-Q) to Rs. 1,599.4 crore, according to Edelweiss.

  • Torrent shareholders clear hike in borrowing limit to Rs 15k crore Mar 01, 2018 06:03 PM IST

    Torrent shareholders clear hike in borrowing limit to Rs 15k crore

    Torrent Pharmaceuticals on Thursday said it has received shareholders' nod to enhance borrowing limit from Rs 10,000 crore to Rs 15,000 crore.

  • Torrent Pharmaceuticals Q3 net profit at Rs 20 crore Feb 08, 2018 10:08 PM IST

    Torrent Pharmaceuticals Q3 net profit at Rs 20 crore

    The company had reported the net profit of Rs 234 crore in the same period last year.

  • Torrent Pharma board okays hiking borrowing limit to Rs 15,000 cr Jan 25, 2018 03:25 PM IST

    Torrent Pharma board okays hiking borrowing limit to Rs 15,000 cr

    As per a BSE filing, the Board also approved "issuance of unsecured/secured redeemable non-convertible debentures/bonds by way of private placement for an amount not exceeding Rs 12,500 crore".

  • Torrent Pharma acquires Bio-Pharm Inc Jan 18, 2018 08:45 PM IST

    Torrent Pharma acquires Bio-Pharm Inc

    Drug firm Torrent Pharmaceuticals today said it has acquired US-based generic pharmaceuticals and OTC firm Bio-Pharm Inc for an undisclosed amount.

  • Torrent Pharma raises Rs 1,000 cr via NCDs Dec 15, 2017 03:52 PM IST

    Torrent Pharma raises Rs 1,000 cr via NCDs

    The company has issued non-convertible debentures for an amount of Rs 1,000 crore on December 14, 2017, Torrent Pharmaceuticals said in a filing to BSE.

  • Torrent completes acquisition of Unichem's branded business Dec 14, 2017 03:52 PM IST

    Torrent completes acquisition of Unichem's branded business

    The transaction is in pursuance of the definitive binding agreement entered into between Torrent and Unichem on November 3, 2017, it added.

  • Buy Torrent Pharmaceuticals; target of Rs 1390: Edelweiss Nov 14, 2017 04:51 PM IST

    Buy Torrent Pharmaceuticals; target of Rs 1390: Edelweiss

    Edelweiss is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1390 in its research report dated November 06, 2017.

  • Will continue to pursue inorganic growth in India & US: Torrent Pharma Nov 07, 2017 12:19 PM IST

    Will continue to pursue inorganic growth in India & US: Torrent Pharma

    In an interview to CNBC-TV18's Ekta Batra and Vikas Dandekar, the Executive Chairman of Torrent Pharma, Samir Mehta spoke about the rationale behind the deal and where it would take the company in the Indian pharmaceutical market.

Sections